Vascular Endothelial Growth Factor Receptor 1 Targeting Fusion Polypeptides with Stimuli-Responsiveness for Anti-angiogenesis-Reference-Cited by-同舟云学术

Vascular Endothelial Growth Factor Receptor 1 Targeting Fusion Polypeptides with Stimuli-Responsiveness for Anti-angiogenesis

Published:2023-06-29 Issue:27 Volume:15 Page:32201-32214
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Kang Min Jeong¹,Roh Kug-Hwan²,Lee Jae Sang¹,Lee Jae Hee¹,Park SaeGwang²,Lim Dong Woo¹^ORCID

Affiliation:

1. Department of Bionano Engineering and Department of Bionanotechnology, Center for Bionano Intelligence Education and Research, Hanyang University, Ansan 15588, Republic of Korea

2. Department of Microbiology and Immunology, College of Medicine, Inje University, Busan 47392, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c03989

Reference74 articles.

1. An overview of FDA-approved biologics medicines

2. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

3. Cell-penetrating and cell-targeting peptides in drug delivery

4. From antimicrobial to anticancer peptides. A review

5. Fusion peptides and the mechanism of viral fusion

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy;Cancers;2024-09-10

2. Platelet rich fibrin and simvastatin-loaded pectin-based 3D printed-electrospun bilayer scaffold for skin tissue regeneration;International Journal of Biological Macromolecules;2024-04